Publications by authors named "Rowina Aljehani"
J Intensive Care Med
June 2023
Article Synopsis
- Tocilizumab (TCZ) may be an effective early treatment for critically ill COVID-19 patients, as it shows potential in reducing multiorgan dysfunction compared to standard care.
- A multicenter cohort study analyzed 300 ICU patients, revealing those who received TCZ within 24 hours had significantly lower multiorgan dysfunction scores and reduced rates of respiratory failure.
- Additionally, patients treated with TCZ exhibited lower 30-day and in-hospital mortality rates, highlighting its benefits in critical COVID-19 care.
